Evidence map›Paper›PMID 26526369›Full record

ArticleCurrent biology : CB2015

TGF-β-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination.

Gaia Cantelli, Jose L Orgaz, Irene Rodriguez-Hernandez, Panagiotis Karagiannis, Oscar Maiques, Xavier Matias-Guiu, Frank O Nestle, Rosa M Marti, Sophia N Karagiannis, Victoria Sanz-Moreno

Open access · hybridAbstract read
In one paragraph

Article in Current biology : CB, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Amoeboid cancer cells at a glance.Journal of cell science · 2026
    Review
  5. Article
  6. Amoeboid-mesenchymal transition and the proteolytic control of cancer invasion plasticity.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. A CD24BMC biology · 2025
    Article
  13. Article
  14. Pan-cancer drivers of metastasis.Molecular cancer · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Roles and signaling pathways of CITED1 in tumors: overview and novel insights.The Journal of international medical research · 2024
    Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Gaia CantelliTumour Plasticity Laboratory, Randall Division of Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, London SE11UL, UK.
Jose L OrgazTumour Plasticity Laboratory, Randall Division of Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, London SE11UL, UK.
Irene Rodriguez-HernandezTumour Plasticity Laboratory, Randall Division of Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, London SE11UL, UK.
Panagiotis KaragiannisSt. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' Hospitals, King's College London, Guy's Campus, London SE1 9RT, UK; Department of Oncology, Haematology and Stem Cell Transplantation, University Hospital of Hamburg Eppendorf, Hamburg 20246, Germany.
Oscar MaiquesDepartment of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova, University of Lleida, IRBLleida, Lleida 25198, Spain.
Xavier Matias-GuiuDepartment of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova, University of Lleida, IRBLleida, Lleida 25198, Spain.
Frank O NestleSt. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' Hospitals, King's College London, Guy's Campus, London SE1 9RT, UK.
Rosa M MartiDepartment of Dermatology, Hospital Universitari Arnau de Vilanova, University of Lleida, IRBLleida, Lleida 25198, Spain.
Sophia N KaragiannisSt. John's Institute of Dermatology, Division of Genetics and Molecular Medicine, Faculty of Life Sciences and Medicine, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' Hospitals, King's College London, Guy's Campus, London SE1 9RT, UK.
Victoria Sanz-MorenoTumour Plasticity Laboratory, Randall Division of Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, London SE11UL, UK. Electronic address: victoria.sanz_moreno@kcl.ac.uk.
King's College London · GBHospital Universitari Arnau de Vilanova · ESBiomedical Research Institute of Lleida · ESNational Institute for Health Research · GBSt Thomas' Hospital · GB

Funding

Cancer Research UK 12065Cancer Research UK C33043/A12065Medical Research Council C97993HMedical Research Council MR/L023091/1
6 · The paper itself

Abstract

Cell migration underlies metastatic dissemination of cancer cells, and fast "amoeboid" migration in the invasive fronts of tumors is controlled by high levels of actomyosin contractility. How amoeboid migration is regulated by extracellular signals and sustained over time by transcriptional changes is not fully understood. Transforming growth factor β (TGF-β) is well known to promote epithelial-to-mesenchymal transition (EMT) and contribute to metastasis, but melanocytes are neural crest derivatives that have undergone EMT during embryonic development. Surprisingly, we find that in melanoma, TGF-β promotes amoeboid features such as cell rounding, membrane blebbing, high levels of contractility, and increased invasion. Using genome-wide transcriptomics, we find that amoeboid melanoma cells are enriched in a TGF-β-driven signature. We observe that downstream of TGF-β, SMAD2 and its adaptor CITED1 control amoeboid behavior by regulating the expression of key genes that activate contractile forces. Moreover, CITED1 is highly upregulated during melanoma progression, and its high expression is associated with poor prognosis. CITED1 is coupled to a contractile-rounded, amoeboid phenotype in a panel of 16 melanoma cell lines, in mouse melanoma xenografts, and in 47 human melanoma patients. Its expression is also enriched in the invasive fronts of lesions. Functionally, we show how the TGF-β-SMAD2-CITED1 axis promotes different steps associated with progression: melanoma detachment from keratinocytes, 2D and 3D migration, attachment to endothelial cells, and in vivo lung metastatic initial colonization and outgrowth. We propose a novel mechanism by which TGF-β-induced transcription sustains actomyosin force in melanoma cells and thereby promotes melanoma progression independently of EMT.

Indexed as

ActomyosinAnimalsApoptosis Regulatory ProteinsCell Line, TumorCell MovementCell ShapeEpithelial-Mesenchymal TransitionHumansKeratinocytesMelanocytesMelanomaMiceMice, NudeNeoplasm MetastasisNuclear ProteinsSmad2 ProteinActomyosinApoptosis Regulatory ProteinsCITED1 protein, humanNuclear ProteinsSmad2 ProteinTrans-ActivatorsTranscription FactorsTransforming Growth Factor beta

Identifiers

PMID26526369
PMCPMC4651903
OpenAlexW2099548111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.